"The GVHD001 long term survival data comes from too few patients (less than 25 had blood taken)"
Right, but to be clear, the long term survival data, is from all the patients N = 51...... not N = 25
The follow up survival study was on the whole trial.
FDA have approved on single arm studies before with less than 24 patients.... we have over 50.
Ann: Trading Halt, page-276
-
- There are more pages in this discussion • 1,075 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 48253 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 32922 | 2 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |